GlassScriptPrepare for your visit
Jeffrey L Marks
Urology · Plantation, FL · NPI 1952346918
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$15,084.51
in general payments reported to CMS, 2019-2025 · $1,545 in 2025
The $1,545 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Who reported paying
General payments only, top 6 by amount.
- Astellas Pharma US INC $4,743.58
- Rochester Medical Corporation $1,475.21
- Janssen Biotech, INC. $1,026.24
- Teleflex LLC $755.11
- Pfizer INC. $686.07
- Abbvie INC. $669.25
Drugs and devices associated with these payments
Erleada Prolaris Orgovyx Xyosted Urolift Lupron Depot Gemtesa Illuccix Trelstar Pluvicto Padcev Botox
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jeffrey Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/817503/jeffrey-l-marks